Asia-Pacific Radiotherapy Market Forecast to 2024: Ken Research
The Asia-Pacific Radiotherapy Market has accounted for USD 1.1 billion in 2016, and is expected to reach USD 2.4 billion by 2024, growing at a CAGR 10.3% during the forecast period 2017 to 2024.
Cancer is the major cause of death in the world and the number of new patients each year is steadily increasing. The most common form of cancer mortality is by metastasis, where the tumors and cancerous cells spread to organs causing failure. The world is focused upon developing solutions and cure to cancer by destroying primary and secondary tumors that cause metastasis.
The key market players for Asia-Pacific Radiotherapy Market are listed below:-
Varian Medical Systems, Inc.
CIVCO Medical Solutions
Ion Beam Applications SA
- R. Bard, Inc.
IsoRay Medical, Inc.
TRF, Nordion, Inc.
RaySearch Laboratories AB
Mevion Medical Systems, Inc.
Mitsubishi Electric Corporation
The market is further segmented into:-
Asia-Pacific radiotherapy market is segmented based on therapy, product, application and geography. Based on the therapy, the radiotherapy market is segmented into external beam radiotherapy, internal beam radiotherapy, and systemic radiation therapy.
Based on the delivery of dose-rate, the internal beam therapy is divided into low (LDR) and high-dose rate (HDR). The LDR segment is expected to account for the largest share of the internal radiotherapy/brachytherapy market, whereas the HDR segment is poised to witness the highest growth.
Based on product type the Asia-Pacific radiotherapy market is segmented into EBRT equipment’s, and IBRT equipment’s.
The External Beam Radiotherapy (EBRT) products are further segmented into cyberknife, gammaknife, LINAC, Proton Beam (Cyclotron, Synclotron).
The Internal Beam Radiotherapy (IBRT) is segmented into seeds, afterloaders and others.
The Asia-Pacific radiotherapy market is also segmented based on indication into cancer of different organs such as brain tumor, spine cancer, lung cancer, liver cancer, breast cancer, prostate cancer and others.
Based on geography, the Asia-Pacific Radiotherapy market is segmented into 11 geographical regions, such as
Covered in this report:-
The report covers the present scenario and the growth prospects of the Asia-Pacific Radiotherapy market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market. You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
For More Information, Click On The Link Below:-
Ankur Gupta, Head Marketing & Communications